With regards to biomarkers, the patients had significantly higher levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and N-terminal pro-brain natriuretic peptide (NT-proBNP) on day 3 after MI than the controls. This evidence concerns the gene NPPB and myocardial infarction.